FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010189504> ?p ?o ?g. }

• W2010189504 endingPage "382" @default.
• W2010189504 startingPage "378" @default.
• W2010189504 abstract "Objective To determine the incidence and risk factors of rash associated with efavirenz in HIV‐infected patients with preceding nevirapine‐associated rash. Methods A retrospective cohort study was conducted in HIV‐infected patients diagnosed with nevirapine‐associated rash who subsequently received efavirenz between July 2003 and January 2005. Patients were followed up for 3 months after receiving efavirenz. Possible risk factors, including demographics, previous opportunistic infections, CD4 cell count, viral load, severity of nevirapine‐associated rash and concurrent drugs, were studied and compared between those who had (group A) and did not have (group B) rash associated with efavirenz. Results A total of 122 patients (52.5% male) were included in the study, with a mean age of 38.2 years. Median (and interquartile range) CD4 cell count and viral load were 55 (20–167) cells/μL and 86 150 (35 321–700 750) HIV‐1 RNA copies/mL, respectively. Of the 122 patients, 10 (8.2%) developed rash associated with efavirenz and all required discontinuation of efavirenz. The baseline characteristics of group A (10 patients) and group B (112 patients) were similar. Median (and interquartile range) time from nevirapine discontinuation to efavirenz initiation was 12 (9–21) days in group A and 11 (7–21) days in group B ( P= 0.765). None of the risk factors investigated was associated with developing rash associated with efavirenz. The preceding development of severe nevirapine‐associated rash had a trend towards a higher rate in group A than in group B (20.0% vs 10.7%; odds ratio=2.08; 95% confidence interval 0.39–10.97; P =0.322). Conclusions The majority (>90%) of HIV‐infected patients with CD4 counts <200 cells/μL who had preceding nevirapine‐associated rash could tolerate efavirenz well. Efavirenz may be an option for subsequent use in these patients, particularly in those who had preceding nevirapine‐associated rash." @default.
• W2010189504 created "2016-06-24" @default.
• W2010189504 creator A5008132510 @default.
• W2010189504 creator A5021244824 @default.
• W2010189504 creator A5037982588 @default.
• W2010189504 creator A5054992584 @default.
• W2010189504 creator A5083235734 @default.
• W2010189504 date "2006-07-24" @default.
• W2010189504 modified "2023-10-11" @default.
• W2010189504 title "Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash" @default.
• W2010189504 cites W1984124421 @default.
• W2010189504 cites W1991979996 @default.
• W2010189504 cites W1999540072 @default.
• W2010189504 cites W2003199949 @default.
• W2010189504 cites W2006774171 @default.
• W2010189504 cites W2009822178 @default.
• W2010189504 cites W2026219081 @default.
• W2010189504 cites W2085066934 @default.
• W2010189504 cites W2152293167 @default.
• W2010189504 cites W2159944585 @default.
• W2010189504 cites W2160159062 @default.
• W2010189504 cites W2160946298 @default.
• W2010189504 cites W2318289184 @default.
• W2010189504 cites W3042812874 @default.
• W2010189504 cites W3191280760 @default.
• W2010189504 cites W4241090604 @default.
• W2010189504 cites W4247068434 @default.
• W2010189504 doi "https://doi.org/10.1111/j.1468-1293.2006.00396.x" @default.
• W2010189504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16903982" @default.
• W2010189504 hasPublicationYear "2006" @default.
• W2010189504 type Work @default.
• W2010189504 sameAs 2010189504 @default.
• W2010189504 citedByCount "28" @default.
• W2010189504 countsByYear W20101895042012 @default.
• W2010189504 countsByYear W20101895042013 @default.
• W2010189504 countsByYear W20101895042014 @default.
• W2010189504 countsByYear W20101895042015 @default.
• W2010189504 countsByYear W20101895042016 @default.
• W2010189504 countsByYear W20101895042017 @default.
• W2010189504 countsByYear W20101895042018 @default.
• W2010189504 countsByYear W20101895042019 @default.
• W2010189504 countsByYear W20101895042021 @default.
• W2010189504 countsByYear W20101895042023 @default.
• W2010189504 crossrefType "journal-article" @default.
• W2010189504 hasAuthorship W2010189504A5008132510 @default.
• W2010189504 hasAuthorship W2010189504A5021244824 @default.
• W2010189504 hasAuthorship W2010189504A5037982588 @default.
• W2010189504 hasAuthorship W2010189504A5054992584 @default.
• W2010189504 hasAuthorship W2010189504A5083235734 @default.
• W2010189504 hasBestOaLocation W20101895041 @default.
• W2010189504 hasConcept C119060515 @default.
• W2010189504 hasConcept C120665830 @default.
• W2010189504 hasConcept C121332964 @default.
• W2010189504 hasConcept C126322002 @default.
• W2010189504 hasConcept C142462285 @default.
• W2010189504 hasConcept C156957248 @default.
• W2010189504 hasConcept C167135981 @default.
• W2010189504 hasConcept C203014093 @default.
• W2010189504 hasConcept C2778570526 @default.
• W2010189504 hasConcept C2778715236 @default.
• W2010189504 hasConcept C2779130552 @default.
• W2010189504 hasConcept C2781432083 @default.
• W2010189504 hasConcept C2993143319 @default.
• W2010189504 hasConcept C3013748606 @default.
• W2010189504 hasConcept C61511704 @default.
• W2010189504 hasConcept C71924100 @default.
• W2010189504 hasConceptScore W2010189504C119060515 @default.
• W2010189504 hasConceptScore W2010189504C120665830 @default.
• W2010189504 hasConceptScore W2010189504C121332964 @default.
• W2010189504 hasConceptScore W2010189504C126322002 @default.
• W2010189504 hasConceptScore W2010189504C142462285 @default.
• W2010189504 hasConceptScore W2010189504C156957248 @default.
• W2010189504 hasConceptScore W2010189504C167135981 @default.
• W2010189504 hasConceptScore W2010189504C203014093 @default.
• W2010189504 hasConceptScore W2010189504C2778570526 @default.
• W2010189504 hasConceptScore W2010189504C2778715236 @default.
• W2010189504 hasConceptScore W2010189504C2779130552 @default.
• W2010189504 hasConceptScore W2010189504C2781432083 @default.
• W2010189504 hasConceptScore W2010189504C2993143319 @default.
• W2010189504 hasConceptScore W2010189504C3013748606 @default.
• W2010189504 hasConceptScore W2010189504C61511704 @default.
• W2010189504 hasConceptScore W2010189504C71924100 @default.
• W2010189504 hasIssue "6" @default.
• W2010189504 hasLocation W20101895041 @default.
• W2010189504 hasLocation W20101895042 @default.
• W2010189504 hasOpenAccess W2010189504 @default.
• W2010189504 hasPrimaryLocation W20101895041 @default.
• W2010189504 hasRelatedWork W1971285141 @default.
• W2010189504 hasRelatedWork W1986122704 @default.
• W2010189504 hasRelatedWork W2014257673 @default.
• W2010189504 hasRelatedWork W2043953605 @default.
• W2010189504 hasRelatedWork W2120838488 @default.
• W2010189504 hasRelatedWork W2140384375 @default.
• W2010189504 hasRelatedWork W2393439851 @default.
• W2010189504 hasRelatedWork W2473556599 @default.
• W2010189504 hasRelatedWork W2900702544 @default.
• W2010189504 hasRelatedWork W3102522326 @default.
• W2010189504 hasVolume "7" @default.

• next